Tag Archives: US Peptide Therapeutics Market

US Peptide Therapeutics Market Will Generate Record Revenue by 2028

The US peptide therapeutics market is anticipated to project a CAGR of 5.0%, during the forecast period. The major factor that contributes to the country’s market growth is continuously increasing healthcare spending. According to the Peptide Therapeutics Foundation, the number of new peptides entering the clinic has been doubled in the past decade. Additionally, the […]